Pharvaris N.V. (PHVS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
PHVS Profit Margin, ROE & Profitability Analysis
PHVS vs Healthcare Sector: How Pharvaris N.V. Compares
How Pharvaris N.V. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Pharvaris N.V. Stock Overvalued? PHVS Valuation Analysis 2026
Based on fundamental analysis, Pharvaris N.V. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Pharvaris N.V. Balance Sheet: PHVS Debt, Cash & Liquidity
PHVS Revenue Growth, EPS Growth & YoY Performance
PHVS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Pharvaris N.V. (CIK: 0001830487)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PHVS
What is the AI rating for PHVS?
Pharvaris N.V. (PHVS) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PHVS's key strengths?
Claude: Analysis in progress.
What are the risks of investing in PHVS?
Claude: Analysis in progress.
What is PHVS's revenue and growth?
Pharvaris N.V. reported revenue of N/A.
Does PHVS pay dividends?
Pharvaris N.V. does not currently pay dividends.
Where can I find PHVS SEC filings?
Official SEC filings for Pharvaris N.V. (CIK: 0001830487) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PHVS's EPS?
Pharvaris N.V. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PHVS's fundamental grade?
Based on our AI fundamental analysis in May 2026, Pharvaris N.V. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PHVS stock overvalued or undervalued?
Valuation metrics for PHVS: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PHVS's AI grade for 2026?
Our dual AI analysis gives Pharvaris N.V. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PHVS's free cash flow?
Pharvaris N.V.'s operating cash flow is N/A, with capital expenditures of N/A.
How does PHVS compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).